Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9Z2G
|
||||
| Drug Name |
(S)-1-(1H-indol-4-yloxy)-3-(4-(4-methoxybenzo[b]thiophen-2-yl)piperidin-1-yl)propan-2-ol
|
||||
| Synonyms |
CHEMBL56795
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H28N2O3S
|
||||
| Canonical SMILES |
COc1cccc2sc(cc12)C3CCN(C[C@H](O)COc4cccc5[nH]ccc45)CC3
|
||||
| InChI |
InChI=1S/C25H28N2O3S/c1-29-22-5-3-7-24-20(22)14-25(31-24)17-9-12-27(13-10-17)15-18(28)16-30-23-6-2-4-21-19(23)8-11-26-21/h2-8,11,14,17-18,26,28H,9-10,12-13,15-16H2,1H3/t18-/m0/s1
|
||||
| InChIKey |
XTXWKNNMEGRBTM-SFHVURJKSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.